2-(Cyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane → 3-Cyclohex-1-enyl-5-nitro-2-(2,2,2-trifluoro-ethoxy)-pyridine
Reaction equation
Br[C:2]1[C:3]([O:11][CH2:12][C:13]([F:16])([F:15])[F:14])=[N:4][CH:5]=[C:6]([N+:8]([O-:10])=[O:9])[CH:7]=1.[C:17]1(B2OC(C)(C)C(C)(C)O2)[CH2:22][CH2:21][CH2:20][CH2:19][CH:18]=1>>[C:17]1([C:2]2[C:3]([O:11][CH2:12][C:13]([F:16])([F:15])[F:14])=[N:4][CH:5]=[C:6]([N+:8]([O-:10])=[O:9])[CH:7]=2)[CH2:22][CH2:21][CH2:20][CH2:19][CH:18]=1Participants
3
Procedure
This compound was prepared following the same procedure as described for Example 1b using 3-bromo-5-nitro-2-(2,2,2-trifluoro-ethoxy)-pyridine (Example 1a, 1 g, 3.18 mmol) and 2-(1-cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAN 141091-37-4, 0.73 g, 3.5 mmol) as starting materials. The title compound (520 mg, 54.0%) was isolated as off white solid; NMR complies.
Workup
- customThis compound was prepared
Sources & evidence
- ORD record
- ord-5b36144d9fee4af5acfe007d11516ff2
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08455501B2
Reaction notes
Loading…